Ensysce Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ensysce Biosciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ENSC | Ensysce Biosciences | -$8.25 | -$2.25 | — | — | $305.72K | — | — | — | 05/12/2025 | Get Alert |
ENSC | Ensysce Biosciences | -$16.95 | -$1.95 | -$2.90 | -48.72% | $515.03K | $245.00K | $1.30M | 432.24% | 03/10/2025 | Get Alert |
ENSC | Ensysce Biosciences | -$13.05 | -$4.35 | $1.05 | 124.14% | $435.38K | $250.00K | $3.42M | 1267.60% | 11/12/2024 | Get Alert |
ENSC | Ensysce Biosciences | -$14.70 | -$5.85 | -$3.30 | 43.59% | $490.47K | $300.00K | $181.80K | -39.40% | 08/14/2024 | Get Alert |
ENSC | Ensysce Biosciences | -$31.20 | -$13.95 | -$8.25 | 40.86% | $789.63K | $400.00K | $305.72K | -23.57% | 05/13/2024 | Get Alert |
ENSC | Ensysce Biosciences | -$273.60 | -$13.05 | -$16.95 | -29.89% | $1.43M | $390.00K | $515.03K | 32.06% | 03/15/2024 | Get Alert |
ENSC | Ensysce Biosciences | -$923.40 | -$15.90 | -$13.05 | 17.92% | $279.35K | $590.00K | $435.38K | -26.21% | 11/09/2023 | Get Alert |
ENSC | Ensysce Biosciences | -$864.00 | -$40.95 | -$14.70 | 64.10% | $207.47K | $826.67K | $490.47K | -4066.89% | 08/11/2023 | Get Alert |
ENSC | Ensysce Biosciences | -$219.90 | -$163.35 | -$31.20 | 80.90% | $603.10K | $950.00K | $789.63K | -16.88% | 05/15/2023 | Get Alert |
ENSC | Ensysce Biosciences | -$1.62K | -$433.80 | -$273.60 | 36.93% | $1.64M | $1.54M | $1.43M | -6.95% | 03/30/2023 | Get Alert |
ENSC | Ensysce Biosciences | -$2.56K | -$576.00 | -$923.40 | -60.31% | $1.20M | $1.00M | $279.35K | -72.06% | 11/14/2022 | Get Alert |
ENSC | Ensysce Biosciences | -$216.00 | -$612.00 | -$864.00 | -41.18% | $444.52K | $1.00M | $207.47K | -79.25% | 08/11/2022 | Get Alert |
ENSC | Ensysce Biosciences | -$216.00 | — | -$216.00 | — | $250.58K | — | $603.10K | — | 05/12/2022 | Get Alert |
ENSC | Ensysce Biosciences | $36.00 | — | -$1.62K | — | $416.49K | $1.00M | $1.64M | 63.50% | 03/31/2022 | Get Alert |
ENSC | Ensysce Biosciences | $324.00 | — | -$2.56K | — | $827.64K | — | $1.20M | — | 11/15/2021 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-10 | $-2.90 | $-1.95 | -48.7 % |
Q3 | 2024-11-12 | $1.05 | $-4.35 | 124.1 % |
Q2 | 2024-08-14 | $-3.30 | $-5.85 | 43.6 % |
Q1 | 2024-05-13 | $-8.25 | $-13.95 | 40.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-10 | $1.30M | $245.00K | 432.2 % |
Q3 | 2024-11-12 | $3.42M | $250.00K | 1267.6 % |
Q2 | 2024-08-14 | $181.80K | $300.00K | -39.4 % |
Q1 | 2024-05-13 | $305.72K | $400.00K | -23.6 % |
Ensysce Biosciences (ENSC) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 10, 2025 for Q4.
The Actual EPS was $-2.90, which missed the estimate of $-1.95.
The Actual Revenue was $1.3M, which beat the estimate of $245K.
Browse earnings estimates, EPS, and revenue on all stocks.